We accelerate Down syndrome research to increase availability of therapeutic, diagnostic, and medical care options and we empower families through education, connections, and support.
LuMind IDSC is the bridge between the Down syndrome community and Down syndrome research.
Statement on accelerated approval of Leqembi to treat mild-stage Alzheimer’s disease in the general population
BECAUSE THEY DID, I CAN, AND WE WILL ADVANCE RESEARCH.
LuMind IDSC invites you and your family to become part of the next chapter: for research that will give us answers.
What’s your DS moment?
HEAR MORE FROM OUR COMMUNITY
Get updates in your inbox about research, our programs and events near you.